ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,693.20
      0.08%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.76
      0.76%
      Bitcoin
      57,164.10
      -0.32%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. InMed Pharmaceuticals Inc (INM)

      7. InMed Pharmaceuticals Inc (INM) News

      INM

      InMed Pharmaceuticals (INM)

      InMed Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:INM
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      12/30/20217:30AMGlobeNewswire Inc.Registration Now Open For Tribe Public’s Webinar Event "Addressing The Increasing Demand For Rare Cannabinoids" Featuring InMed’s Management Team On January 6, 2022NASDAQ:INMInMed Pharmaceuticals Inc
      12/22/202111:22AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:INMInMed Pharmaceuticals Inc
      12/20/20217:30AMGlobeNewswire Inc.InMed Pharmaceuticals Announces Publication of Peer-Reviewed Article on the Use of CBN as a Potential Treatment for GlaucomaNASDAQ:INMInMed Pharmaceuticals Inc
      12/20/20216:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      12/17/20217:57PMGlobeNewswire Inc.InMed Announces Results of 2021 Annual General MeetingNASDAQ:INMInMed Pharmaceuticals Inc
      11/23/20211:33PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      11/23/20217:30AMGlobeNewswire Inc.InMed Pharmaceuticals to Participate in Cowen’s 4th Annual Cannabis ConferenceNASDAQ:INMInMed Pharmaceuticals Inc
      11/15/20213:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      11/10/20217:32AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INMInMed Pharmaceuticals Inc
      11/10/20217:30AMGlobeNewswire Inc.InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business UpdateNASDAQ:INMInMed Pharmaceuticals Inc
      11/09/20213:51PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INMInMed Pharmaceuticals Inc
      11/03/20212:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      11/03/20217:30AMGlobeNewswire Inc.InMed Pharmaceuticals Files PCT Patent Application for Treating Neurodegenerative Disease Using a Rare CannabinoidNASDAQ:INMInMed Pharmaceuticals Inc
      10/28/20213:08PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INMInMed Pharmaceuticals Inc
      10/28/20212:55PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INMInMed Pharmaceuticals Inc
      10/28/20211:30PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      10/28/202111:30AMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:INMInMed Pharmaceuticals Inc
      10/19/20216:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      10/19/20216:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      10/19/20216:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      10/19/20216:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      10/19/20216:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      10/13/20215:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      10/13/20214:30PMGlobeNewswire Inc.InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare CannabinoidsNASDAQ:INMInMed Pharmaceuticals Inc
      10/01/20214:47PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      09/30/20211:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      09/30/20211:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      09/30/20217:30AMGlobeNewswire Inc.InMed Pharmaceuticals Announces Commencement of Phase 2 Clinical Trial Investigating Cannabinol (CBN), a Rare Cannabinoid, in the Treatment of Epidermolysis BullosaNASDAQ:INMInMed Pharmaceuticals Inc
      09/29/20212:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:INM

      Your Recent History

      BIT
      UB25VM
      UniCredit Bank
      Delayed Upgrade Clock